rs11764718

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000089.4(COL1A2):​c.3955-242G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 549,634 control chromosomes in the GnomAD database, including 15,430 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3261 hom., cov: 32)
Exomes 𝑓: 0.24 ( 12169 hom. )

Consequence

COL1A2
NM_000089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.441

Publications

11 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 7-94430005-G-A is Benign according to our data. Variant chr7-94430005-G-A is described in ClinVar as Benign. ClinVar VariationId is 1248714.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.354 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A2NM_000089.4 linkc.3955-242G>A intron_variant Intron 51 of 51 ENST00000297268.11 NP_000080.2 P08123A0A0S2Z3H5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A2ENST00000297268.11 linkc.3955-242G>A intron_variant Intron 51 of 51 1 NM_000089.4 ENSP00000297268.6 P08123
COL1A2ENST00000481570.5 linkn.5310G>A non_coding_transcript_exon_variant Exon 8 of 8 2
COL1A2ENST00000464916.1 linkn.1003-242G>A intron_variant Intron 3 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.189
AC:
28665
AN:
152050
Hom.:
3260
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0744
Gnomad AMI
AF:
0.183
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.255
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.368
Gnomad FIN
AF:
0.125
Gnomad MID
AF:
0.282
Gnomad NFE
AF:
0.239
Gnomad OTH
AF:
0.225
GnomAD4 exome
AF:
0.238
AC:
94645
AN:
397466
Hom.:
12169
Cov.:
4
AF XY:
0.246
AC XY:
52235
AN XY:
211948
show subpopulations
African (AFR)
AF:
0.0765
AC:
877
AN:
11470
American (AMR)
AF:
0.271
AC:
4665
AN:
17226
Ashkenazi Jewish (ASJ)
AF:
0.261
AC:
3188
AN:
12204
East Asian (EAS)
AF:
0.149
AC:
3976
AN:
26622
South Asian (SAS)
AF:
0.362
AC:
15720
AN:
43388
European-Finnish (FIN)
AF:
0.141
AC:
3019
AN:
21340
Middle Eastern (MID)
AF:
0.309
AC:
537
AN:
1738
European-Non Finnish (NFE)
AF:
0.238
AC:
57227
AN:
240384
Other (OTH)
AF:
0.235
AC:
5436
AN:
23094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
3501
7001
10502
14002
17503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.188
AC:
28663
AN:
152168
Hom.:
3261
Cov.:
32
AF XY:
0.187
AC XY:
13898
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.0743
AC:
3084
AN:
41522
American (AMR)
AF:
0.241
AC:
3683
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
886
AN:
3468
East Asian (EAS)
AF:
0.182
AC:
941
AN:
5176
South Asian (SAS)
AF:
0.368
AC:
1776
AN:
4826
European-Finnish (FIN)
AF:
0.125
AC:
1327
AN:
10596
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.239
AC:
16247
AN:
67970
Other (OTH)
AF:
0.224
AC:
473
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1148
2296
3443
4591
5739
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.228
Hom.:
3896
Bravo
AF:
0.190
Asia WGS
AF:
0.252
AC:
876
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.0
DANN
Benign
0.28
PhyloP100
-0.44
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11764718; hg19: chr7-94059317; API